Epidemiological Features and Resistance Pattern in Uropathogens Isolated from Chronic Bacterial Prostatitis

Tommaso Cai; Sandra Mazzoli; Francesca Meacci; Vieri Boddi; Nicola Mondaini; Gianni Malossini; Riccardo Bartoletti

doi:10.1007/s12275-011-0391-z

Articles

Page Path: HOME > J. Microbiol > Volume 49(3); 2011 > Article

Journal Article
Epidemiological Features and Resistance Pattern in Uropathogens Isolated from Chronic Bacterial Prostatitis: Tommaso Cai ¹, Sandra Mazzoli ², Francesca Meacci ², Vieri Boddi ³, Nicola Mondaini ⁴, Gianni Malossini ¹, Riccardo Bartoletti ⁴; Journal of Microbiology 2011;49(3):448-454.
DOI: https://doi.org/10.1007/s12275-011-0391-z
Published online: June 30, 2011

¹Department of Urology, Santa Chiara Hospital, Trento 38123, Italy, ²Sexually Transmitted Disease Centre, Santa Maria Annunziata Hospital, Florence 50011, Italy, ³Department of Public Health and Epidemiology, University of Florence, Florence 50011, Italy, ⁴Department of Urology, University of Florence, Florence 50011, Italy

Corresponding author: Tommaso Cai , Tel: +39-0461-903306,

Received: 29 September 2010 • Accepted: 27 January 2011

prev next

65 Views
0 Download
32 Crossref
47 Scopus

Full Article

Abstract

Chronic bacterial prostatitis (CBP) is, usually, caused by uropathogens, especially gram-negative bacilli, although infection is sometimes due to Gram-positive and atypical microorganisms. A recent increasing in prevalence of Gram-positive strains has been reported. The aim of this study was to explore the epidemiological features and resistance rates in uropathogens isolated from CBP outpatients in last 10 years. All consecutive outpatients with demonstrated CBP attending a single Sexually Transmitted Disease centre from January 1997 and December 2008, were enrolled and underwent microbiological cultures in first void early morning urine, midstream urine, expressed prostatic secretion, and post prostate massage urine. Prevalence of different bacterial strains was stratified in four different periods: 1997-1999, 2000-2002, 2003-2005, 2006-2008. Any changes observed in epidemiological features and resistance rates in uropathogens over the whole study period have been analyzed. The present study has been planned, thus, as in vitro study. From 6,221 patients, 4,601 Gram-positive and 1,620 Gram-negative bacterial strains have been isolated. Enterococcus faecalis and Escherichia coli strains are the first and second frequent pathogens found, respectively. Significant differences between E. faecalis prevalence in the 1997-1999 and 2006-2008 periods were found. E. coli showed a significant difference between prevalence in 1997-1999 and 2006-2008 periods. Gram-positive organisms showed a decreasing of susceptibility to ciprofloxacin as well as Gram-negative strains, while a good susceptibility to the levofloxacin was evidenced. E. faecalis prevalence seemed to be raised in 2006-2008 periods. Moreover, a decreasing of activity of ciprofloxacin and a good activity profile of levofloxacin have been reported.

Keywords: bacterial prostatitis;Gram-positive;Gram-negative;antibacterial agents;antibiotic susceptibility

Figure & Data

References

Citations

Citations to this article as recorded by

Could Urology’s Antimicrobial Stewardship Be Enhanced by the Routine Use of the Meares and Stamey Test?
Simone Botti, Tommaso Ceccato, Michele Rizzo, Giovanni Liguori, Alessandro Zucchi, Alessandro Palmieri, Truls E. Bjerklund Johansen, Tommaso Cai
Diagnostics.2025; 15(8): 1002. CrossRef
Urobiome and Inflammation: A Systematic Review on Microbial Imbalances and Diagnostic Tools for Urinary Disorders
Sara Palumbo, Giuseppe Lucarelli, Francesco Lasorsa, Rocco Damiano, Riccardo Autorino, Achille Aveta, Gianluca Spena, Sisto Perdonà, Pierluigi Russo, Carlo Giulioni, Angelo Cafarelli, Marco Finati, Salvatore Siracusano, Savio Domenico Pandolfo
Urology.2025;[Epub] CrossRef
Pathogen Detection and Diagnostic Scenarios in Chronic Prostatitis
Vittorio Magri, Gianpaolo Perletti, Konstantinos Stamatiou
Diagnostics.2025; 15(6): 762. CrossRef
Microbiota of prostate secretion in patients with chronic abacterial prostatitis
Z. A. Kadyrov, M. V. Faniev, Sh. V. Ramishvili, V. S. Stepanov, A. V. Ignatev, Sh. G. Mashaneishvili
Andrology and Genital Surgery.2024; 25(1): 73. CrossRef
Molecular detection of urinary microbiome in prostate cancer patients
Shadab Mestri, Satisha Hegde, Makhadumsab Toragall, Sridevi I. Puranik, M. A. Mujeeb, Shridhar C. Ghagane
Journal of The Academy of Clinical Microbiologists.2024; 25(2): 44. CrossRef
Prevalence and antibiotic susceptibility patterns of uropathogens in men with prostate cancer and benign prostate hyperplasia from Southwestern Nigeria
Sharon O. Akinpelu, Grace I. Olasehinde, Stephen O. Ikuerowo, Olayemi O. Akinnola
BMC Microbiology.2024;[Epub] CrossRef
Comparative analysis of the microbiota of prostate secretion in patients with chronic abacterial prostatitis of categories IIIa and IIIb
Z. A. Kadyrov, M. V. Faniev, Sh. V. Ramishvili, V. S. Stepanov, A. V. Ignatev, Sh. G. Mashaneishvili
Andrology and Genital Surgery.2024; 25(2): 93. CrossRef
Successful use of a phage endolysin for treatment of chronic pelvic pain syndrome/chronic bacterial prostatitis
Roy H. Stevens, Hongming Zhang, Michal Kajsik, Rafał Płoski, Malgorzata Rydzanicz, Peter Sabaka, Stanislav Šutovský
Frontiers in Medicine.2023;[Epub] CrossRef
Pharmacotherapeutic interventions for the treatment of bacterial prostatitis
Ester Marquez-Algaba, Joaquin Burgos, Benito Almirante
Expert Opinion on Pharmacotherapy.2022; 23(9): 1091. CrossRef
Safety considerations with new antibacterial approaches for chronic bacterial prostatitis
Gianpaolo Perletti, Alberto Trinchieri, Konstantinos Stamatiou, Vittorio Magri
Expert Opinion on Drug Safety.2022; 21(2): 171. CrossRef
Reflux-related Complications in Patients with Chronic Calculous Prostatitis and Benign Prostate Hyperplasia After Surgical Removal of Prostatic Hyperplasia and Stones
Mykhailo Ukhal, Oleh Semaniv, Ivan Pustovoit, Heorhii Samunzhi
Health of Man.2022; (4): 42. CrossRef
One, No One and One Hundred Thousand: Patterns of chronic prostatic inflammation and infection
Konstantinos Stamatiou, Evangelia Samara, Richard Lacroix, Hippocrates Moschouris, Gianpaolo Perletti, Vittorio Magri
Experimental and Therapeutic Medicine.2021;[Epub] CrossRef
Does the microbiota spectrum of prostate secretion affect the clinical status of patients with chronic bacterial prostatitis?
Mikhail Kogan, Yulia Naboka, Akhmed Ferzauli, Khalid Ibishev, Irina Gudima, Ruslan Ismailov
International Journal of Urology.2021; 28(12): 1254. CrossRef
Pharmacological Interventions for Bacterial Prostatitis
Situ Xiong, Xiaoqiang Liu, Wen Deng, Zhengtao Zhou, Yulei Li, Yechao Tu, Luyao Chen, Gongxian Wang, Bin Fu
Frontiers in Pharmacology.2020;[Epub] CrossRef
Current Knowledge of the Potential Links between Inflammation and Prostate Cancer
Tommaso Cai, Raffaella Santi, Irene Tamanini, Ilaria Camilla Galli, Gianpaolo Perletti, Truls E. Bjerklund Johansen, Gabriella Nesi
International Journal of Molecular Sciences.2019; 20(15): 3833. CrossRef
Actividad y concentraciones de antibióticos en muestras clínicas de pacientes con prostatitis crónica bacteriana
V. Heras-Cañas, B. Gutiérrez-Soto, H. Almonte-Fernández, A. Lara-Oya, J.M. Navarro-Marí, A. Garrido-Frenich, F. Vázquez-Alonso, J. Gutiérrez-Fernández
Actas Urológicas Españolas.2017; 41(10): 631. CrossRef
Antibiotic activity and concentrations in clinical samples from patients with chronic bacterial prostatitis
V. Heras-Cañas, B. Gutiérrez-Soto, H. Almonte-Fernández, A. Lara-Oya, J.M. Navarro-Marí, A. Garrido-Frenich, F. Vázquez-Alonso, J. Gutiérrez-Fernández
Actas Urológicas Españolas (English Edition).2017; 41(10): 631. CrossRef
Mounting resistance of uropathogens to antimicrobial agents: A retrospective study in patients with chronic bacterial prostatitis relapse
Konstantinos Stamatiou, Nikolaos Pierris
Investigative and Clinical Urology.2017; 58(4): 271. CrossRef
Prostatitis crónica bacteriana. Estudio clínico y microbiológico de 332 casos
Víctor Heras-Cañas, Blanca Gutiérrez-Soto, María Luisa Serrano-García, Fernando Vázquez-Alonso, José María Navarro-Marí, José Gutiérrez-Fernández
Medicina Clínica.2016; 147(4): 144. CrossRef
Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis
Ibai Los-Arcos, Carles Pigrau, Dolors Rodríguez-Pardo, Nuria Fernández-Hidalgo, Antonia Andreu, Nieves Larrosa, Benito Almirante
Antimicrobial Agents and Chemotherapy.2016; 60(3): 1854. CrossRef
Chronic bacterial prostatitis. Clinical and microbiological study of 332 cases
Víctor Heras-Cañas, Blanca Gutiérrez-Soto, María Luisa Serrano-García, Fernando Vázquez-Alonso, José María Navarro-Marí, José Gutiérrez-Fernández
Medicina Clínica (English Edition).2016; 147(4): 144. CrossRef
Decreased expression of Toll-like receptor 4 and 5 during progression of prostate transformation in transgenic adenocarcinoma of mouse prostate mice
Ju-Hee Han, Jong-Hwan Park, Bo-Yeon Kim, Seo-Na Chang, Tae-Hyoun Kim, Jae-Hak Park, Dong-Jae Kim
Journal of Veterinary Science.2015; 16(3): 281. CrossRef
A comparison of monomicrobial versus polymicrobial Enterococcus faecalis bacteriuria in a French University Hospital
C. Fourcade, L. Canini, J.-P. Lavigne, A. Sotto
European Journal of Clinical Microbiology & Infectious Diseases.2015; 34(8): 1667. CrossRef
Chronic bacterial prostatitis in men with spinal cord injury
Jörg Krebs, Peter Bartel, Jürgen Pannek
World Journal of Urology.2014; 32(6): 1579. CrossRef
Nonsteroidal Anti-Inflammatory Drugs and Prostatic Diseases
Hitoshi Ishiguro, Takashi Kawahara
BioMed Research International.2014; 2014: 1. CrossRef
Salmonella prostatitis in a man with spinal cord injury
Jörg Krebs, Konrad Göcking, Jürgen Pannek
The Journal of Spinal Cord Medicine.2014; 37(1): 114. CrossRef
The impact of biofilm-producing bacteria on chronic bacterial prostatitis treatment: results from a longitudinal cohort study
Riccardo Bartoletti, Tommaso Cai, Gabriella Nesi, Sara Albanese, Francesca Meacci, Sandra Mazzoli, Kurt Naber
World Journal of Urology.2014; 32(3): 737. CrossRef
Atypical Microorganisms in Expressed Prostatic Secretion from Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Microbiological Results from a Case-Control Study
Jiaquan Xiao, Ligang Ren, Huoxiang Lv, Qing Ding, Shuixin Lou, Wei Zhang, Zhichao Dong
Urologia Internationalis.2013; 91(4): 410. CrossRef
Antimicrobial Resistance Pattern inEnterococcus faecalisStrains Isolated From Expressed Prostatic Secretions of Patients With Chronic Bacterial Prostatitis
Yumi Seo, Gilho Lee
Korean Journal of Urology.2013; 54(7): 477. CrossRef
The Role of Asymptomatic Bacteriuria in Young Women With Recurrent Urinary Tract Infections: To Treat or Not to Treat?
T. Cai, S. Mazzoli, N. Mondaini, F. Meacci, G. Nesi, C. D'Elia, G. Malossini, V. Boddi, R. Bartoletti
Clinical Infectious Diseases.2012; 55(6): 771. CrossRef
Prostate cancer and inflammation: the evidence
Karen S Sfanos, Angelo M De Marzo
Histopathology.2012; 60(1): 199. CrossRef
Chronic Bacterial Prostatitis: Enterococcal Disease?
V. Magri, E. Marras, G. Perletti
Clinical Infectious Diseases.2011; 53(12): 1306. CrossRef

Cite this Article

Cite this Article: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Epidemiological Features and Resistance Pattern in Uropathogens Isolated from Chronic Bacterial Prostatitis

J. Microbiol. 2011;49(3):448-454. Published online June 30, 2011

DOI: https://doi.org/10.1007/s12275-011-0391-z

Related articles